
CELLARICH EXOSOME
EXCLUSIVELY DESIGNED FOR PLATELET RICH BIOGEL PREPARATION
From a leading Canadian manufacturer, CellaRich Exosome is a platelet rich BioGel preparation kit designed to harness the power of autologous exosomes and growth factors. Our innovative solution unlocks the potential of BioGel containing high concentrations of autologous exosomes and growth factors for the US clinical market. CellaRich Exosome kit is specifically designed for preparation of BioGel rich in autologous exosomes and growth factors, suitable for use with diode laser/spinning process.
CELLARICH EXOSOME
UNLOCKING AUTOLOGOUS EXOSOME POTENTIAL

CHOOSE THE BEST OPTION FOR YOUR NEEDS

UNDERSTANDING CELLARICH EXOSOME
Platelet rich BioGel is a gel-like substance containing high concentrations of platelets, autologous exosomes, and growth factors. It's obtained by centrifuging autologous blood and preparing a BioGel rich in autologous exosomes and growth factors, suitable for use with diode laser/spinning process.
Key Benefits
-
Efficient BioGel preparation for the extended release
-
High-yield autologous exosome and growth factor content
-
Versatile options to suit your needs
CellaRich Exosome Advantage:
-
Enhanced autologous exosome preservation
-
Optimized growth factor recovery
-
Superior BioGel stability
-
Improved handling and application
-
Extended release of autologous exosomes, growth factors, and platelets
ENHANCED FOR
PLATELET RICH EXOSOME FORMATION
CellaRich Exosome presents a paradigm shift in regenerative medicine, offering distinct advantages over traditional platelet-rich plasma (PRP) tubes. Notably, CellaRich Exosome differs from conventional PRP tubes in several key aspects.


Note: Cellarich Exosome is a medical device for preparation, not the biological PRP product itself.
Disclaimer: This website and its contents are for professional use only by licensed medical practitioners within the United States market. The product information and intended use described herein are directed toward the US market only. Certain products and protocols may not be approved for sale or clinical use in all countries; usage is strictly reserved for geographical regions where explicit marketing authorization has been granted by the relevant health authorities.


